Detection of TERT gene mutations in tumor tissues

Determination of mutations in the promoter region of the TERT gene is recommended for the diagnosis of thyroid cancer, as well as for postoperative risk stratification of thyroid cancer recurrence in order to determine postoperative patient management tactics. Determination of mutations in this gene is recommended for patients with glial tumors to personalize treatment tactics.

Within 14 days. The specified time does not include the day of biomaterial collection